Research
Size:
Share:
Search studies by: All,
Active,
Completed

ECLIPSE 1004B – Sponsored by Ophthotech Corp.

Completed Study | Duration: 12 months

ECLIPSE 1004B was a multinational, prospective, randomized Phase III clinical trial for the treatment of wet Age-Related Macular Degeneration (wet AMD). It compared... View study

SPECTRI – Sponsored by Hoffmann-La Roche

Completed Study | Duration: 96 weeks

The Retina Group of Washington (RGW) was the only practice in the Washington metropolitan area to have served as a center for this trial. It was the first Phase III... View study

A prospective, multicenter clinical trial of the Implantable Miniature Telescope (IMT™) in patients with central vision impairment associated with Age-Related Macular... View study

ECLIPSE 1002 – Sponsored by Ophthotech Corp.

Completed Study | Duration: 12 months

ECLIPSE 1002 was a multinational, prospective, randomized Phase III clinical trial for the treatment of wet Age-Related Macular Degeneration (wet AMD). It compared... View study

The findings from this study will advance our understanding of the longer-term effects of anti-VEGF drugs on choroidal neovascularization (CNV) and the retina providing... View study

This trial was for patients with wet AMD who had received multiple treatments of either Lucentis®, Avastin® or Eylea® (anti-VEGF therapy) and had responded... View study

In collaboration with the National Eye Institute, Notal Vision is conducting a national study to determine if home monitoring using the ForeseeHome device in... View study

RGW worked with newly-diagnosed wet aAge-related Macular Degeneration (AMD) patients for this important study, the recently published results of which concluded that... View study